Home › Funds › New York Life › NYLI Global Equity R&D Leaders ETF
Fund family: New York Life · Filed by New York Life Investments ETF Trust (CIK 1415995) · SEC series S000074744
Ticker: WRND (C000232897)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,586 with, 94 against, 4 abstentions (not counted as with management); 13 items carried no recommendation; 3 split votes are in neither count. Shareholder proposals: 32 FOR, 66 AGAINST, 6 abstained, by the filing’s own vote-source field.
The same two figures as New York Life’s manager page (58,397 ballot items across 52 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | New York Life | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 91.8% | 2,087 | 92.5% | 47,807 |
| Backed environmental and social shareholder proposals at US companies | n/a | 47 | 14.2% | 772 |
Each ballot item this fund voted is set against the votes of the other New York Life funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most New York Life funds on 8 items (0.9% of the 939 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most New York Life funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Oracle Corporation | 2025-11-18 | Election of Directors: Awo Ablo | Withhold | FOR — 5 of 7 New York Life funds | Against | Elected, 83.9% support |
| Oracle Corporation | 2025-11-18 | Election of Directors: Bruce R. Chizen | Withhold | FOR — 5 of 7 New York Life funds | Against | Elected, 76.1% support |
| Oracle Corporation | 2025-11-18 | Advisory Vote to Approve the Compensation of our Named Executive Officers | Against | FOR — 5 of 8 New York Life funds | Against | Passed (calculated), 81.9% support |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Britt Meelby Jensen as New Director | Abstain | FOR — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Cees de Jong (Vice Chair) as New Director | Abstain | FOR — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Lars Rebien Sorensen (Chair) as New Director | Abstain | FOR — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Mikael Dolsten as New Director | Abstain | FOR — 2 of 3 New York Life funds | — | — |
| Novo Nordisk A/S | 2025-11-14 | Shareholder Elect Stephan Engels as New Director | Abstain | FOR — 2 of 3 New York Life funds | — | — |
Download all 8 differences (CSV)
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,373 | 1 |
| Corporate Governance | 512 | 29 |
| Capital Structure | 251 | 3 |
| Compensation | 238 | 6 |
| Audit-related | 159 | 0 |
| Say-on-Pay | 78 | 0 |
| Other Social Issues | 32 | 23 |
| Environment or Climate | 20 | 20 |
| Extraordinary Transactions | 17 | 0 |
| Other | 11 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Meta Platforms, Inc. | May 27, 2026 | $677,776 | 22 | 8 |
| Apple Inc. | February 24, 2026 | $645,587 | 12 | 1 |
| NVIDIA Corporation | June 24, 2026 | $616,909 | 16 | 4 |
| Alphabet Inc. | June 5, 2026 | $587,017 | 23 | 10 |
| Microsoft Corporation | December 5, 2025 | $542,854 | 21 | 6 |
| Amazon.com, Inc. | May 20, 2026 | $483,281 | 17 | 4 |
| Broadcom Inc. | April 20, 2026 | $314,730 | 10 | 0 |
| Eli Lilly and Company | May 4, 2026 | $302,479 | 10 | 2 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding dual class capital structure. Shareholder proposal | For | Against |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting the replacement of supermajority voting provisions in our charter and bylaws with a simple majority voting standard. Shareholder proposal | For | Against |
| June 24, 2026 | NVIDIA Corporation | Approval of a non-binding stockholder proposal requesting a report on faith-based community resource groups. Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding an enhanced disclosure on climate goals Shareholder proposal | Against | For |
| June 5, 2026 | Alphabet Inc. | Shareholder proposal regarding a report on water usage and AI development Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING A REPORT ON CHARITABLE PARTNERSHIPS Shareholder proposal | Against | For |
| May 20, 2026 | Amazon.com, Inc. | SHAREHOLDER PROPOSAL REQUESTING ADDITIONAL REPORTING ON IMPACT OF DATA CENTERS ON CLIMATE COMMITMENTS Shareholder proposal | Against | For |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
2,708 ballot items at 210 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, NYLI Global Equity R&D Leaders ETF (WRND) voted at 210 shareholder meetings of 199 companies, on 2,708 ballot items in all. Where management made a recommendation, the fund followed it on 96.3% of the items and voted against it 94 times. Its most frequent area of disagreement was corporate governance (29 of its votes against management). It voted FOR 32.7% of the 98 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals less often than New York Life's funds as a whole (91.8% against 92.5%). It voted differently from most New York Life funds on 8 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of New York Life’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.